Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: Implications for future impact on prevention

International Journal of Cancer

Volumn 132, Issue 4, 2012, Pages 932-943

  Steens, Anneke ^a   Wielders, Cornelia C H ^a,b   Bogaards, Johannes A ^a,c   Boshuizen, Hendriek C ^a   De Greeff, Sabine C ^a   De Melker, Hester E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Pallas Health Research and Consultancy BV   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

epidemiologic factors; human papillomavirus vaccines; mass screening; models; theoretical; uterine cervical cancer

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANCER IMMUNIZATION; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SOCIAL STATUS; URBAN AREA; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

ADOLESCENT; ADULT; CHILD; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; MOTHERS; NETHERLANDS; NUCLEAR FAMILY; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT PARTICIPATION; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84871363426     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27671     Document Type: Article

References (50)

1. Bogaards JA, Coupe VM, Xiridou M, et al. Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence. Epidemiology 2011; 22: 505-15.
2. Rebolj M, van Ballegooijen M, Berkers LM, et al. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in The Netherlands. Int J Cancer 2007; 120: 806-12. (Pubitemid 46175400)
3. Bulk S, Visser O, Rozendaal L, et al. Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area. Br J Cancer 2003; 89: 834-9. (Pubitemid 37175804)
4. van der Aa MA, Schutter EM, Looijen-Salamon M, et al. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001. Eur J Obstet Gynecol Reprod Biol 2008; 139: 204-9.
5. European Medicines Agency. Summary of product characteristics for Cervarix. 2009 December 2.
6. Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011; 128: 927-35.
7. Szarewski A, Poppe W, Skinner S, et al. Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer 2011; 131: 106-16.
8. Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007; 369: 2161-70. (Pubitemid 46977438)
9. Glass J, Bengtson VL, Dunham CC,. Attitude similarity in three-generation families: socialization, status inheritance, or reciprocal influence. Am Sociol Rev 1986; 51: 685-98.
10. Dohmen T, Falk A, Huffman D, et al. The intergenerational transmission of risk and trust attitudes. Rev Econ Stud 2011;doi: 10.1093/restud/rdr027.
11. Chao C, Slezak JM, Coleman KJ, et al. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 2009; 99: 1137-42.
12. Lefevere E, Hens N, Theeten H, et al. Like mother, like daughter? Mother's history of cervical cancer screening and daughter's human papillomavirus vaccine uptake in Flanders (Belgium). Vaccine 2011; 29: 8390-96.
13. Barnabas RV, Laukkanen P, Koskela P, et al. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med 2006; 3: e138.
14. van de Velde N, Brisson M, Boily MC,. Understanding differences in predictions of HPV vaccine effectiveness: a comparative model-based analysis. Vaccine 2010; 28: 5473-84.
15. Coupe VM, van Ginkel J, De Melker HE, et al. HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness. Int J Cancer 2009; 124: 970-8.
16. Thiry N, De Laet C, Hulstaert F, et al. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening. Int J Technol Assess Health Care 2009; 25: 161-70.
17. Kim JJ, Goldie SJ,. Health and economic implications of HPV vaccination in the United States. N Engl J Med 2008; 359: 821-32.
18. Jit M, Choi YH, Edmunds WJ,. Economic evaluation of human papillomavirus vaccination in the United Kingdom. Br Med J 2008; 337: a769.
19. Chou B, Krill LS, Horton BB, et al. Disparities in human papillomavirus vaccine completion among vaccine initiators. Obstet Gynecol 2011; 118: 14-20.
20. van Leeuwen AW, de Nooijer P, Hop WC,. Screening for cervical carcinoma. Cancer 2005; 105: 270-6.
21. van Lier A, Oomen P, Drijfhout I, et al. Præventis, the immunisation register of The Netherlands: a tool to evaluate the national immunisation programme. Eurosurveillance 2012; 17: pii = 20153.
22. Statistics Netherlands. Dutch demographics. Available at: http://statline.cbs.nl/statweb/.
23. Knippenberg H, Stoppelenburg CM, Wusten HH,. De protestantenband van Nederland: de geografische spreiding der orthodox-protestanten in 1920 en 1985/86. KNAG Geografisch Tijdschrift 1986; 23: 12-22.
24. Ruijs WL, Hautvast JL, van der Velden K, et al. Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study. Biomed Chromatogr Public Health 2011; 11: 102.
25. Rondy M, van Lier A, van de KJ, et al. Determinants for HPV vaccine uptake in The Netherlands: a multilevel study. Vaccine 2010; 28: 2070-5.
26. Gelman A, Hill J,. Data analysis using regression and multilevel-hierarchical models. Cambridge: Cambridge University Press, 2007.
27. Bulkmans NW, Berkhof J, Rozendaal L, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007; 370: 1764-72. (Pubitemid 350137476)
28. Bulkmans NW, Berkhof J, Bulk S, et al. High-risk HPV type-specific clearance rates in cervical screening. Br J Cancer 2007; 96: 1419-24. (Pubitemid 46685773)
29. Bogaards JA, Xiridou M, Coupe VM, et al. Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus. Am J Epidemiol 2010; 171: 817-25.
30. Coupe VM, Berkhof J, Bulkmans NW, et al. Age-dependent prevalence of 14 high-risk HPV types in The Netherlands: implications for prophylactic vaccination and screening. Br J Cancer 2008; 98: 646-51. (Pubitemid 351214513)
31. Deubner DC, Wilkinson WE, Helms MJ, et al. Logistic model estimation of death attributable to risk factors for cardiovascular disease in Evans County, Georgia. Am J Epidemiol 1980; 112: 135-43. (Pubitemid 10019010)
32. Greenland S, Drescher K,. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics 1993; 49: 865-72. (Pubitemid 23298363)
33. The Netherlands Perinatal Registry. Perinatal care in The Netherlands 2008. April 2011.
34. Anhang Price R, Koshiol J, Kobrin S, et al. Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine 2011; 29: 4238-43.
35. van Lier A,. Vaccination coverage National Immunisation Program, The Netherlands. Report of 2011. 2012. Report No.: 210021014/2011.
36. Henderson L, Clements A, Damery S, et al. A false sense of security? Understanding the role of the HPV vaccine on future cervical screening behaviour: a qualitative study of UK parents and girls of vaccination age. J Med Screen 2011; 18: 41-5.
37. Bauch CT, Li M, Chapman G, et al. Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low? Lancet Infect Dis 2010; 10: 133-7.
38. Kulasingam SL, Pagliusi S, Myers E,. Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S. Vaccine 2007; 25: 8110-3. (Pubitemid 350046322)
39. Health Council of The Netherlands. Population screening for cervical cancer. The Hague: Health Council of The Netherlands; May 24, 2011. Report No.: 2011/07.
40. Mollema L, Wijers N, Hahne SJ, et al. Participation in and attitude towards the national immunization program in The Netherlands: data from population-based questionnaires. Biomed Chromatogr Public Health 2012; 12: 57.
41. van der Aa MA, Siesling S, Louwman MW, et al. Geographical relationships between sociodemographic factors and incidence of cervical cancer in The Netherlands 1989-2003. Eur J Cancer Prev 2008; 17: 453-9.
42. Newmann SJ, Garner EO,. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 2005; 16: 63-70. (Pubitemid 40568852)
43. Walsh CD, Gera A, Shah M, et al. Public knowledge and attitudes towards human papilloma virus (HPV) vaccination. Biomed Chromatogr Public Health 2008; 8: 368.
44. Marlow LA, Waller J, Wardle J,. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007; 25: 1945-52. (Pubitemid 46227684)
45. Marlow LA, Forster AS, Wardle J, et al. Mothers' and adolescents' beliefs about risk compensation following HPV vaccination. J Adolesc Health 2009; 44: 446-51.
46. Guerry SL, De Rosa CJ, Markowitz LE, et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011; 29: 2235-41.
47. Litton AG, Desmond RA, Gilliland J, et al. Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama. J Pediatr Adolesc Gynecol 2011; 24: 166-71.
48. Statistics Netherlands. Trend report national youth monitor 2010 [In Dutch].
49. Wobma E,. Population trends, 1st quarter of 2011; Men and women in The Netherlands [In Dutch]. Statistics Netherlands; 2011.
50. Knol F,. From high to low; from low to high: the social development of districts between 1971 and 1995 [In Dutch]. The Hague: The Netherlands Institute for Social Research (SCP); 1998.